- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Soma Gold Corp.
Black Swan Graphene
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
BioCorRx released their financial report for the second quarter of 2017 and provided a business update to shareholders.
BioCorRx (OTCQB:BICX) released their financial report for the second quarter of 2017 and provided a business update to shareholders.
As quoted in the press release:
Brady Granier, President, CEO, and Director, stated, “We are pleased to report a 12% increase in revenue for the second quarter ended June 30, 2017. The increase in revenue is due to the increased number of clinics, as well as patients treated at clinics already licensed to offer our BioCorRx Recovery Program. In July, we entered into agreements with centers in three different states that will be implementing the BioCorRx Recovery Program. Our program is a non-addictive, medication-assisted treatment (MAT) program that combines a naltrexone implant with a proprietary counseling program and peer support specifically tailored for the treatment of alcoholism and opioid use disorder. In South Florida, we are now working with Hope Recovery and Wellness in West Palm Beach, which will be the first center in that area to implement the BioCorRx Recovery Program. EnLite™ Clinics is the first center to introduce our program in Ohio (at three locations), which is considered by many to be the epicenter of the opioid crisis. Lastly, we announced that Serrano KVAC clinic, an affiliate of the Serrano Kidney and Vascular Access Center of California, in conjunction with Serrano KVAC’s partner CereCare, LLC, will implement the BioCorRx Recovery Program for the Hispanic market in Los Angeles, California. This marks the first clinic offering our program specifically for the Hispanic market.”
Click here to read the full press release.
Source: www.accesswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.